Cargando…

Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis

A comprehensive evaluation of the risk of serious infections in biologic therapies for psoriasis is lacking. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) and prospective cohort studies reporting serious infections in people taking any licensed biologic th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiu, Zenas Z.N., Exton, Lesley S., Jabbar-Lopez, Zarif, Mohd Mustapa, M. Firouz, Samarasekera, Eleanor J., Burden, A. David, Murphy, Ruth, Owen, Caroline M., Parslew, Richard, Venning, Vanessa, Ashcroft, Darren M., Griffiths, Christopher E.M., Smith, Catherine H., Warren, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946794/ https://www.ncbi.nlm.nih.gov/pubmed/27085754 http://dx.doi.org/10.1016/j.jid.2016.03.035

Ejemplares similares

Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis
por: Jabbar-Lopez, Zarif K., et al.
Publicado: (2017)

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Zenas Z.N., et al.
Publicado: (2018)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley, Tessa, et al.
Publicado: (2016)

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength
por: Thorneloe, Rachael J., et al.
Publicado: (2018)

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Z.Z.N., et al.
Publicado: (2018)

Recapturing adequate control of psoriasis by additional immunosuppressive agents alongside ustekinumab
por: Jayasekera, Prativa S., et al.
Publicado: (2016)

Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register
por: Yiu, Zenas Z. N., et al.
Publicado: (2020)

Genetic susceptibility to psoriasis: an emerging picture
por: Smith, Rhodri Ll, et al.
Publicado: (2009)

Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case–control studies
por: Abo-Tabik, Maha, et al.
Publicado: (2022)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study
por: Rungapiromnan, W., et al.
Publicado: (2019)

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Iskandar, Ireny Y.K., et al.
Publicado: (2018)

A rapid access clinic for psoriasis: first experiences
por: Reid, Claire, et al.
Publicado: (2022)

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
por: Mason, K.J., et al.
Publicado: (2019)

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
por: Parisi, Rosa, et al.
Publicado: (2020)

Clinical Disease Measures in Generalized Pustular Psoriasis
por: Burden, A. David, et al.
Publicado: (2022)

Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
por: Drucker, Aaron Mark, et al.
Publicado: (2018)

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study
por: Wilkinson, Nina, et al.
Publicado: (2019)

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021)

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
por: Thorneloe, R.J., et al.
Publicado: (2016)

The challenges of assessing patients' medication beliefs: a qualitative study
por: Thorneloe, Rachael J., et al.
Publicado: (2017)

Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
por: Chen, Teng-Chou, et al.
Publicado: (2023)

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Concordance and timing in recording cancer events in primary care, hospital and mortality records for patients with and without psoriasis: A population-based cohort study
por: Trafford, Alex M., et al.
Publicado: (2021)

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
por: Iskandar, I.Y.K., et al.
Publicado: (2017)

Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population‐based cohort study using electronic health data routinely captured in the Teleprimary Care (TPC (®)) clinical information system from 2010 to 2020
por: Choon, Siew Eng, et al.
Publicado: (2022)

The global state of psoriasis disease epidemiology: a workshop report
por: Griffiths, C.E.M., et al.
Publicado: (2017)

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk
por: KLEYN, C. Elise, et al.
Publicado: (2020)

Impaired Langerhans cell migration in psoriasis
por: Cumberbatch, Marie, et al.
Publicado: (2006)

Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey
por: Bechman, Katie, et al.
Publicado: (2022)

A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
por: Cro, Suzie, et al.
Publicado: (2020)

Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor
por: Gooderham, M., et al.
Publicado: (2019)

Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study
por: Phan, Duc Binh, et al.
Publicado: (2023)

Treatment of severe psoriasis with infliximab
por: Leman, JA, et al.
Publicado: (2008)

Psoriasis, COVID‐19 and shielding
por: Becher, G., et al.
Publicado: (2021)

A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
por: Cornelius, Victoria, et al.
Publicado: (2018)

Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study
por: Springate, D.A., et al.
Publicado: (2016)

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
por: Lecaros, C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1gtcna4tut1u1b3k7lrk8dn54e